Mutation Profile of Metastatic Castration-Resistant Prostate Cancer Patients Prior to Olaparib Treatment - EMA vs. FDA

被引：0
|
作者：
Dragos, Vita Setrajcic [1 ]
Stegel, Vida [1 ]
Klancar, Gasper [1 ]
Skerl, Petra [1 ]
Klasinc, Anja Zagozen [1 ]
Novakovic, Srdjan [1 ]
机构：
[1] Inst Oncol Ljubljana, Dept Mol Diagnost, Ljubljana, Slovenia
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2023年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P13.070.D
引用
收藏
页码：548 / 549
页数：2
相关论文
共 50 条
  • [41] Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer
    Schweizer, Michael T.
    Gulati, Roman
    Yezefski, Todd
    Cheng, Heather H.
    Mostaghel, Elahe
    Haffner, Michael C.
    Patel, Radhika A.
    De Sarkar, Navonil
    Ha, Gavin
    Dumpit, Ruth
    Woo, Brianna
    Lin, Aaron
    Panlasigui, Patrick
    McDonald, Nerina
    Lai, Michael
    Nega, Katie
    Hammond, Jeannette
    Grivas, Petros
    Hsieh, Andrew
    Montgomery, Bruce
    Nelson, Peter S.
    Yu, Evan Y.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (01) : 194 - 200
  • [42] International experience of using olaparib for metastatic castration-resistant prostate cancer: literature review
    Matveev, V. B.
    Khalmurzaev, O. A.
    Evsyukova, O., I
    ONKOUROLOGIYA, 2020, 16 (04): : 197 - 206
  • [43] Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine Learning
    Deng, Kaiwen
    Li, Hongyang
    Guan, Yuanfang
    ISCIENCE, 2020, 23 (02)
  • [44] Update on options for treatment of metastatic castration-resistant prostate cancer
    Vishnu, Prakash
    Tan, Winston W.
    ONCOTARGETS AND THERAPY, 2010, 3 : 39 - 51
  • [45] The changing landscape in the treatment of metastatic castration-resistant prostate cancer
    El-Amm, Joelle
    Aragon-Ching, Jeanny B.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2013, 5 (01) : 25 - 40
  • [46] The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
    Tsao, Che-Kai
    Cutting, Elena
    Martin, Jacob
    Oh, William K.
    THERAPEUTIC ADVANCES IN UROLOGY, 2014, 6 (03) : 97 - 104
  • [47] Optimal Treatment Sequence for Metastatic Castration-resistant Prostate Cancer
    Lorente, David
    Fizazi, Karim
    Sweeney, Christopher
    de Bono, Johann S.
    EUROPEAN UROLOGY FOCUS, 2016, 2 (05): : 488 - 498
  • [48] FDA APPROVES FIRST TREATMENT FOR NONMETASTATIC, CASTRATION-RESISTANT PROSTATE CANCER
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2018, 118 (06) : 26 - 26
  • [49] Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide
    Baciarello, Giulia
    Sternberg, Cora N.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 106 : 14 - 24
  • [50] RADIUM 223 FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Miranda, Jesus
    Vinal, David
    Pinto, Alvaro
    ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (05): : 500 - 507
12345